Fouad Namouni, PRESIDENT, R & D at Blueprint Medicines Corp (BPMC), sold 3,833 shares at $45.72 ($175K) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Open-market sale of $175k BPMC by PRESIDENT, R & D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.36 | 63 | $3K | 1.6% |
| 2 | $45.72 | 1,885 | $86K | 49.2% |
| 3 | $45.72 | 1,885 | $86K | 49.2% |
| Total | $45.70 avg | 3,833 | $175K | 100% |
| Filing → |
| BPMC | SELL | 2024-03-11 | $794K | — | Filing → |
| BPMC | SELL | 2023-10-05 | $362K | — | Filing → |
| BPMC | SELL | 2022-10-05 | $468K | — | Filing → |